TSE:APHA - Aphria Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aphria Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$4.02 -0.27 (-6.29 %) (As of 04/2/2020 07:31 AM ET) Add Compare Today's RangeC$3.98Now: C$4.02▼C$4.3050-Day RangeC$3.03MA: C$4.51▼C$5.7052-Week RangeC$2.65Now: C$4.02▼C$13.57Volume2.78 million shsAverage Volume3.70 million shsMarket CapitalizationC$1.07 billionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartEarningsHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc. is headquartered in Leamington, Canada.Read More Industry, Sector and Symbol Stock Exchange TSE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolTSE:APHA Previous Symbol CUSIPN/A CIKN/A Webhttp://www.aphria.com/ Phone844-427-4742Debt Debt-to-Equity Ratio28.80 Current Ratio5.43 Quick Ratio3.69Price-To-Earnings Trailing P/E RatioN/A Forward P/E Ratio100.50 P/E GrowthN/A Sales & Book Value Annual SalesC$448.41 million Price / Sales2.39 Cash FlowC$1.97 per share Price / Cash Flow2.04 Book ValueC$6.84 per share Price / Book0.59Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees300 Outstanding Shares267,134,000Market CapC$1.07 billion Next Earnings DateN/A OptionableOptionable Receive APHA News and Ratings via Email Sign-up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter. TSX:APHA Rates by TradingView Aphria (TSE:APHA) Frequently Asked Questions How has Aphria's stock been impacted by COVID-19 (Coronavirus)? Aphria's stock was trading at C$3.68 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, APHA stock has increased by 9.2% and is now trading at C$4.02. View which stocks have been mosted impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Aphria? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Aphria. What price target have analysts set for APHA? 5 equities research analysts have issued 1-year target prices for Aphria's shares. Their forecasts range from C$6.50 to C$16.00. On average, they expect Aphria's stock price to reach C$9.48 in the next year. This suggests a possible upside of 135.7% from the stock's current price. View analysts' price targets for Aphria. Has Aphria been receiving favorable news coverage? Media headlines about APHA stock have trended very negative on Thursday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Aphria earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutAphria. Who are some of Aphria's key competitors? Some companies that are related to Aphria include Evotec (EVT), Aurora Cannabis (ACB), Knight Therapeutics (GUD), HLS Therapeutics (HLS), Ecofibre (EOF), OrganiGram (OGI), Hexo (HEXO), Next Science (NXS), ICC Labs (ICC), HEXO (HEXO), Benchmark (BMK), Amryt Pharma (AMYT), Probiotec (PBP), CannTrust (TRST) and Auscann Group (AC8). What other stocks do shareholders of Aphria own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Canopy Growth (CGC), Aurora Cannabis (ACB), OrganiGram (OGI), KushCo (KSHB), CannTrust (CTST), NVIDIA (NVDA), HEXO (HEXO) and Cronos Group (CRON). Who are Aphria's key executives? Aphria's management team includes the following people: Mr. Carl A. Merton, Chief Financial OfficerMs. Megan McCrae, VP of MarketingMr. Irwin D. Simon, Interim CEO & ChairmanMr. Jakob Ripshtein, PresMr. Brett D. Marchand, Sr. VP of Operations What is Aphria's stock symbol? Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APHA." How do I buy shares of Aphria? Shares of APHA and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Aphria's stock price today? One share of APHA stock can currently be purchased for approximately C$4.02. How big of a company is Aphria? Aphria has a market capitalization of C$1.07 billion and generates C$448.41 million in revenue each year. Aphria employs 300 workers across the globe. View additional information about Aphria. What is Aphria's official website? The official website for Aphria is http://www.aphria.com/. How can I contact Aphria? Aphria's mailing address is 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada. The company can be reached via phone at 844-427-4742. MarketBeat Community Rating for Aphria (TSE APHA)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 367 (Vote Outperform)Underperform Votes: 330 (Vote Underperform)Total Votes: 697MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote "Outperform" if you believe APHA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APHA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/2/2020 by MarketBeat.com StaffFeatured Article: What is Liquidity?
